<table id="ID97" width="101%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 3. Mean (±SD) Plasma Acyclovir Pharmacokinetic Parameters Following Administration of Valacyclovir Hydrochloride to Healthy Adult Volunteers</caption>
<col span="1" width="15%"></col>
<col span="1" width="39%"></col>
<col span="1" width="4%"></col>
<col span="1" width="39%"></col>
<col span="1" width="4%"></col>
<tbody>
<tr>
<td>
<br/>
<br/>
<br/>
<br/>Dose <br/>
</td>
<td>Single-Dose Administration<br/>(N = 8)<br/>
</td>
<td>
<br/>
</td>
<td>Multiple-Dose Administration <sup>a</sup>(N = 24, 8 per treatment arm)</td>
<td>
<br/>
</td>
</tr>
<tr>
<td> <br/>
</td>
<td>C<sub>m</sub>
<sub>a</sub>
<sub>x</sub> (±SD)  (mcg/mL)<br/>
</td>
<td>AUC (±SD) (hr●mcg/mL)<br/>
</td>
<td>C<sub>m</sub>
<sub>a</sub>
<sub>x</sub> (±SD) (mcg/mL)<br/>
</td>
<td>AUC (±SD) (hr●mcg/mL)<br/>
</td>
</tr>
<tr>
<td>100 mg <br/>
</td>
<td>0.83 (±0.14) <br/>
</td>
<td>2.28 (±0.40) <br/>
</td>
<td>ND<br/>
</td>
<td>ND<br/>
</td>
</tr>
<tr>
<td>250 mg <br/>
</td>
<td>2.15 (±0.50) <br/>
</td>
<td>5.76 (±0.60) <br/>
</td>
<td>2.11 (±0.33)<br/>
</td>
<td>5.66 (±1.09)<br/>
</td>
</tr>
<tr>
<td>500 mg <br/>
</td>
<td>3.28 (±0.83) <br/>
</td>
<td>11.59 (±1.79) <br/>
</td>
<td>3.69 (±0.87)<br/>
</td>
<td>9.88 (±2.01)<br/>
</td>
</tr>
<tr>
<td>750 mg <br/>
</td>
<td>4.17 (±1.14) <br/>
</td>
<td>14.11 (±3.54) <br/>
</td>
<td>ND<br/>
</td>
<td>ND<br/>
</td>
</tr>
<tr>
<td>1,000 mg <br/>
</td>
<td>5.65 (±2.37) <br/>
</td>
<td>19.52 (±6.04) <br/>
</td>
<td>4.96 (±0.64)<br/>
</td>
<td>15.70 (±2.27)<br/>
</td>
</tr>
<tr>
<td>
<paragraph>
<sup>a</sup>
<sup></sup>Administered 4 times daily for 11 days. <br/>
</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>ND = not done<br/>
</paragraph>
</td>
</tr>
</tbody>
</table>